Company Filing History:
Years Active: 1997-2001
Title: Brij Khera: A Pioneer in Pharmaceutical Innovations
Introduction
Brij Khera is an accomplished inventor based in New Delhi, India, known for his significant contributions to the field of pharmaceuticals. With three patents to his name, he has made remarkable strides in the development of innovative processes in drug formulation.
Latest Patents
Among Brij Khera's notable inventions are two groundbreaking patents. The first patent details a "Process for the preparation of 1,8-disubstituted-1,3,4,9-tetrahydropyrano (3,4-B)-indole-1-acetic acid esters". This innovative process outlines the preparation of esters related to the indole-1-acetic acid, which holds potential therapeutic benefits. The second patent focuses on the "Process for the manufacture of pharmaceutical grade ranitidine base". This process is crucial as it describes the manufacture of a key pharmaceutical compound, demonstrating efficacy and safety comparable to the established Form 2 ranitidine hydrochloride, as evidenced by extensive pharmacological and toxicity studies.
Career Highlights
Brij Khera has built a career as a valuable member of Ranbaxy Laboratories, Inc., where he leverages his expertise to drive pharmaceutical advancements. His dedication to research and innovation underscores his commitment to improving healthcare outcomes through effective medicinal solutions.
Collaborations
Throughout his career, Brij has collaborated with fellow professionals, including colleagues Naresh Kumar and Jag Mohan Khanna. Together, they share a focus on advancing pharmaceutical technologies and creating novel therapeutic agents that address pressing medical needs.
Conclusion
Brij Khera's contributions to the field of pharmaceuticals through his patents and collaborative efforts signify his role as an influential inventor. His work continues to pave the way for innovative drug formulations that hold promise for improving patient care and treatment efficacy.